Alzamend Neuro, Inc. (ALZN)
1.02
-0.04
(-3.77%)
USD |
NASDAQ |
Apr 01, 16:00
0.9833
-0.04
(-3.60%)
After-Hours: 20:00
Alzamend Neuro Total Assets (Quarterly) : 4.042M for Jan. 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | 415.90M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.857M |
| Shareholders Equity (Quarterly) | 2.184M |
| Current Ratio | 1.992 |